CHEK2 C1100del mutation associated with papillary renal cell carcinoma type II

Elsevier

Available online 12 May 2023, 102421

Urology Case ReportsAuthor links open overlay panel, , Abstract

CHEK2 mutations have been noted in bone, brain, breast, colon, lung, thyroid, and prostate cancer. Although now reported in both clear cell and non-clear cell renal cancer, we have not found CHEK2 2 mutations reported in the papillary type II subtype (PRCC). Here, we report a 63-year-old female with a PRCC type II with a concomitant CHEK2 C1100del mutation, who is currently in complete remission three years post tumor resection.

Keywords

CHEK2

Mutation

Papillary

RCC

Type II

© 2023 Published by Elsevier Inc.

留言 (0)

沒有登入
gif